Late acute liver allograft rejection; A study of its natural history and graft survival in the current era

Transplantation

Volumn 95, Issue 7, 2013, Pages 955-959

  Thurairajah, Prem H ^a   Carbone, Marco ^a   Bridgestock, Hannah ^a   Thomas, Philip ^a   Hebbar, Srisha ^a   Gunson, Bridget K ^a,b   Shah, Tahir ^a   Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b University of Birmingham   (United Kingdom)

Author keywords

Acute cellular rejection; Chronic cellular rejection; Immunosuppression; Late acute rejection; Liver transplantation

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGE; AGED; BILIARY CIRRHOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; DUCTOPENIC REJECTION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ACUTE DISEASE; ADULT; BIOPSY; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876291554     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182845f6c     Document Type: Review

References (31)

1. Klintmalm GB, Nery JR, Husberg BS, et al. Rejection in liver transplantation. Hepatology 1989; 10: 978.
2. Quiroga J, Colina I, Demetris AJ, et al. Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients. Hepatology 1991; 14: 1054.
3. Anand AC, Hubscher SG, Gunson BK, et al. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995; 60: 1098.
4. Farges O, Saliba F, Farhamant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240.
5. Ramji A, Yoshida EM, Bain VG, et al. Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl 2002; 8: 945.
6. Uemura T, Ikegami T, Sanchez EQ, et al. Late acute rejection after liver transplantation impacts patient survival. Clin Transplant 2008; 22: 316.
7. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658.
8. Hubscher SG. Transplantation pathology. Semin Liver Dis 2009; 29: 74.
9. Demetris AJ, Murase N, Delaney CP, et al. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc 1995; 27: 67.
10. Demetris AJ, Murase N, Lee RG, et al. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997; 2: 27.
11. Demetris AJ, Adeyi O, Bellamy CO, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489.
12. Hubscher SG. Transplantation pathology. Semin Diagn Pathol 2006; 23: 170.
13. Abraham SC, Freese DK, Ishitani MB, et al. Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol 2008; 32: 1479.
14. Krasinskas AM, Demetris AJ, Poterucha JJ, et al. The prevalence and natural history of untreated isolated central perivenulitis in adult al-lograft livers. Liver Transpl 2008; 14: 625.
15. Mor E, Gonwa TA, Husberg BS, et al. Late-onset acute rejection in orthotopic liver transplantationVassociated risk factors and outcome. Transplantation 1992; 54: 821.
16. Demetris AJ, Ruppert K, Dvorchik I, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002; 74: 1290.
17. Dousset B, Conti F, Cherruau B, et al. Is acute rejection deleterious to long-term liver allograft function? J Hepatol 1998; 29: 660.
18. Wiesner RH, Steffen BJ, David KM, et al. Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients. Am J Transplant 2006; 6: 1609.
19. Maheshwari A, Torbenson MS, Thuluvath PJ. Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immu-nosuppression after liver transplantation. Dig Dis Sci 2006; 51: 1677.
20. Soin AS, Rasmussen A, Jamieson NV, et al. CsA levels in the early posttransplant periodVpredictive of chronic rejection in liver transplantation? Transplantation 1995; 59: 1119.
21. Ludwig J, Hashimoto E, Porayko MK, et al. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. Liver Transpl Surg 1996; 2: 185.
22. Pirsch JD, Kalayoglu M, Hafez GR, et al. Evidence that the vanishing bile duct syndrome is vanishing. Transplantation 1990; 49: 1015.
23. Wiesner RH, Batts KP, Krom RA. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transpl Surg 1999; 5: 388.
24. Akamatsu N, Sugawara Y, Tamura S, et al. Late-onset acute rejection after living donor liver transplantation. World J Gastroenterol 2006; 12: 6674.
25. Florman S, Schiano T, Kim L, et al. The incidence and significance of late acute cellular rejection (91000 days) after liver transplantation. Clin Transplant 2004; 18: 152.
26. Ratziu V, Samuel D, Sebagh M, et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999; 30: 131.
27. Milkiewicz P, Gunson B, Saksena S, et al. Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors. Transplantation 2000; 70: 477.
28. Staatz CE, Taylor PJ, Lynch SV, et al. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transpl 2004; 10: 506.
29. Bishop GA, Sun J, Sheil AG, et al. High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation 1997; 64: 1377.
30. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: implications for immunosup-pressive therapy. Liver Transpl 2001; 7: 161.
31. Neil DA, Hubscher SG. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23: 971.